PARK14 patients with homozygous (D331Y) PLA2G6 mutation display motor deficits of pure early-onset Parkinson's disease (PD). The aim of this study is to investigate the pathogenic mechanism of mutant (D331Y) PLA2G6-induced PD. We generated knockin (KI) mouse model of PARK14 harboring homozygous (D331Y) PLA2G6 mutation. Then, we investigated neuropathological and neurological phenotypes of PLA2G6 KI mice and molecular pathogenic mechanisms of (D331Y) PLA2G6-induced degeneration of substantia nigra (SN) dopaminergic neurons. Six-or nine-month-old PLA2G6Y KI mice displayed early-onset cell death of SNpc dopaminergic neurons. Lewy body pathology was found in the SN of PLA2G6 mice. Six-or nine-month-old PLA2G6 KI mice exhibited early-onset parkinsonism phenotypes. Disrupted cristae of mitochondria were found in SNpc dopaminergic neurons of PLA2G6 mice. PLA2G6 mice displayed mitochondrial dysfunction and upregulated ROS production, which may lead to activation of apoptotic cascade. Upregulated protein levels of Grp78, IRE1, PERK, and CHOP, which are involved in activation of ER stress, were found in the SN of PLA2G6 mice. Protein expression of mitophagic proteins, including parkin and BNIP3, was downregulated in the SN of PLA2G6 mice, suggesting that (D331Y) PLA2G6 mutation causes mitophagy dysfunction. In the SN of PLA2G6 mice, mRNA levels of eight genes that are involved in neuroprotection/neurogenesis were decreased, while mRNA levels of two genes that promote apoptotic death were increased. Our results suggest that PARK14 (D331Y) PLA2G6 mutation causes degeneration of SNpc dopaminergic neurons by causing mitochondrial dysfunction, elevated ER stress, mitophagy impairment, and transcriptional abnormality.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12035-018-1118-5DOI Listing

Publication Analysis

Top Keywords

pla2g6 mice
32
d331y pla2g6
20
dopaminergic neurons
20
pla2g6 mutation
16
pla2g6
13
mitochondrial dysfunction
12
snpc dopaminergic
12
mice
9
park14 d331y
8
degeneration substantia
8

Similar Publications

Human genetics identify convergent signals in mitochondrial LACTB-mediated lipid metabolism in cardiovascular-kidney-metabolic syndrome.

Cell Metab

November 2024

Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA; Penn/CHOP Kidney Innovation Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Genetics, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address:

Article Synopsis
  • Researchers discovered that the beta-lactamase gene (LACTB) is linked to kidney dysfunction and high lipid levels, which are vital aspects of cardiovascular-kidney-metabolic syndrome.
  • In experiments, mice lacking LACTB showed symptoms of impaired glucose tolerance and higher lipid levels, while overexpressing LACTB in specific kidney tubules provided protection against kidney damage.
  • The study reveals that LACTB acts as a mitochondrial protease that activates another gene, PLA2G6, which is important for regulating lipid metabolism and may serve as a target for treating metabolic disorders related to kidney health.
View Article and Find Full Text PDF

Red blood cell (RBC) metabolism regulates hemolysis during aging in vivo and in the blood bank. However, the genetic underpinnings of RBC metabolic heterogeneity and extravascular hemolysis at population scale are incompletely understood. Based on the breeding of 8 founder strains with extreme genetic diversity, the Jackson laboratory diversity outbred population can capture the impact of genetic heterogeneity in like fashion to population-based studies.

View Article and Find Full Text PDF
Article Synopsis
  • Calcium-independent phospholipase A2γ (iPLA2γ) plays a role in kidney health, with its deletion in mice leading to mitochondrial issues and heightened autophagy in kidney cells, yet not causing albuminuria directly.
  • In a study involving diabetic models, iPLA2γ knockout (KO) mice did not show the expected increase in albuminuria compared to control mice, even with similar hyperglycemia levels.
  • The findings suggest that the absence of iPLA2γ offers protection against chronic kidney damage during diabetes, linked to enhanced autophagy in the glomeruli.
View Article and Find Full Text PDF

Differential lipid signaling from CD4 and CD8 T cells contributes to type 1 diabetes development.

Front Immunol

October 2024

Department of Cell, Developmental, and Integrative Biology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.

Introduction: We reported that Ca-independent phospholipase Aβ (iPLAβ)-derived lipids (iDLs) contribute to type 1 diabetes (T1D) onset. As CD4 and CD8 T cells are critical in promoting β-cell death, we tested the hypothesis that iDL signaling from these cells participates in T1D development.

Methods: CD4 and CD8 T cells from wild-type non-obese diabetic () and .

View Article and Find Full Text PDF

iPLA2β loss leads to age-related cognitive decline and neuroinflammation by disrupting neuronal mitophagy.

J Neuroinflammation

September 2024

National Kunming High-Level Biosafety Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, 935 Jiaoling Road, Kunming, 650118, Yunnan, China.

Background: During brain aging, disturbances in neuronal phospholipid metabolism result in impaired cognitive function and dysregulation of neurological processes. Mutations in iPLA2β are associated with neurodegenerative conditions that significantly impact brain phospholipids. iPLA2β deficiency exacerbates mitochondrial dysfunction and abnormal mitochondrial accumulation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!